The Division of Hematology/Oncology offers expertise in the diagnosis and treatment of a broad spectrum of blood disorders and malignant diseases. The Hemology/Oncology faculty participate in specialized patient care and research programs in the areas of solid tumors, hematologic malignancies, thrombosis, bleeding disorders, sickle cell anemia, and bone marrow transplantation. In association with other members of the UNC Lineberger Comprehensive Cancer Center, specialized interdisciplinary oncology clinics and conferences are held weekly in the areas of breast cancer, thoracic, gastrointestinal, genitourinary, sarcoma, neuro-oncology, melanoma, and head and neck malignancies. Centers which are central to implementing the patient care and research missions of the Division include the Lineberger Comprehensive Cancer Center, one of the foremost cancer research centers in the country, and the nationally recognized Hemostasis and Thrombosis, Hemophilia, and Sickle Cell Centers.

Hematology & Oncology News

  • stephan-moll

    Moll Publishes Guidance For Unexplained Arterial Thromboembolism

    Stephan Moll, MD, professor of medicine in the division of hematology, has published the clinical educational article “How I Treat: Unexplained Arterial Thromboembolism” in Blood, the journal of the American Society of Hematology.  The article bridges hematology, vascular medicine, neurology, cardiology and general medicine, discussing existing knowledge about etiology and clinical management of unexplained arterial … Continued

  • dougald-monroe

    Monroe Receives NIH Award To Help Guide Development of New Therapeutics For Bleeding

    Dougald Monroe, PhD, professor medicine in the division of hematology and member of the UNC Blood Research Center, has received an NIH NHLBI award. The R01HL151984 grant “An integrated computational and experimental approach to understanding the hemostatic response during treatment of bleeding” was awarded four years of funding and will enable researchers to create better … Continued

  • thumbnail-tschernia-voorhees

    Tschernia, Voorhees Receive Fellowship Grants From AACR

    Two faculty physicians from the division of oncology are in the newest class of American Association for Cancer Research (AACR) grant recipients. Nicholas Tschernia, MD, has received the 2020 AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship. Timothy J. Voorhees, MD, has received the 2020 AACR-AstraZeneca Lymphoma Research Fellowship for “Pilot study of anti-PD-1 therapy following CD30 … Continued

More Hematology & Oncology News